| Aipes-Eeig.org » New Technologies » New Technologies Group
Mission Statement Group Activities


New Technologies: Group 
 
 
 
 

 


Antonis Kalemis, PhD., Chairman
PhD in Medical Physics (ICR - University of London);
At Philips Healthcare since 2007;

Global Clinical Science Manager - PET/MR

Serge Askienazy
President EANM 1991 - 1993 - EANM Paris 2000
Head of Nuclear Medicine Department 1969, Hôpital Ste Anne - Hôpital St Antoine, Paris,
Professor of Biophysics and Nuclear Medicine,/ Teaching og Nuclear Medicine for France;
Director Medical Research, Cyclopharma Laboratoires, France
   


Gerard Ber, PhD.,
25 years long standing experience in nuclear medicine;
General Manager at Adanced Accelerator Applications (AAA), France


Mart-Jan Blauwhoff,
Certified Technology and Nuclear Medicine Technician
5 years as chief technician NM dept VU Amsterdam,
25+ years in NM and radiology industry in marketing and sales,
Senior European Product Director EMEA Covidien

 


Philippe Damhaut, PhD.,
PhD in chemistry (PET radiochemistry) from University of Liège, Belgium
7 years experience in University Nuclear Medicine Department (research and production);

With MDS Nordion since 2001: production, research and development
Director New Opportunities Best Medical

 


Michael Nader, Phd.,
Study of Chemistry (University of Heidelberg);
PhD in Radiopharmaceutical Chemistry (German Cancer Research Centre, Heidelberg);
Research Associate, Duke University Medical Centre, Durham, NC (USA).
Production Manager International, Head of R&D at IASON GmbH.

 


Frédéric Schoenahl, Phd.,
Medical/electrical engineering degree In France/Germany, anatomic and functional imaging, MSc;
Research, stochastic image processing group at U. Geneva and U. Hospital Geneva, Switzerland;
PhD at Geneva University.
PETCT expert, acceptance, sales and collaborations (instrumentation, image), by Siemens Healthcare Molecular Imaging.


Dr. Konrade von Bremen
Specialist in Internal Medicine
Associate Medical Director of the University Hospital Lausanne (CH)
Clinical Director of the Neuro Division of Medtronic EHQ in Tolochenaz (CH)
Various research and teaching appointments with Universities in Switzerland and Italy
Served as expert to the EU Commission and to the Swiss Federal Office of Public Health
CEO of the SWAN-Group (Bern, Switzerland)


Richard Zimmermann, PhD.,
Chemistry engineer, PhD in organic chemistry;
25 years of experience in pharmaceutical industry with 10 years in nuclear medecine;
Researcher (Beecham and Solvay Pharma), Project Director (Solvay), Director R&D (CIS bio international).
VP Radiopharmceutical Development, IBA Molecular
.



Thomas Beyer, Consultant

Studies of Physics in Germany and UK,
Trained in PET and multi-modality imaging technology;
Previous engagement in CTI/Siemens and Philips Academia and Imaging CRO;
Founder and President of cmi-experts GmbH, Zurich